Besides, naïve and effector memory CD4+ T cells develop a more aggressive MS phenotype characterized by down-regulation of mitochondrial biomass markers and ultrastructural mitochondrial abnormalities [114]; while peripheral blood nuclear cells (PBMCs) obtained from MS patients display low reductive activity and increased ROS generation [112]. This evidence concerns the gene CD4 and myeloid sarcoma.